Sean O'Brien
Keine laufenden Positionen mehr
Profil
Mr. Sean O'Brien is an Analyst at YYC Capital Management LLC.
Prior to joining YYC Capital Management in June 2011, Mr. O'Brien was employed as a Principal by Eli Lilly & Co., an Associate by Advanced Tissue Sciences, Inc., Research Assistant by Vertex Pharmaceuticals, Inc., a Research Associate by Arena Pharmaceuticals, Inc., and an Assistant by The Salk Institute for Biological Studies.
Mr. O'Brien received his undergraduate degree in Finance from Suffolk University and an MBA from Suffolk University.
Ehemalige bekannte Positionen von Sean O'Brien
| Unternehmen | Position | Ende |
|---|---|---|
YYC Capital Management LLC
 YYC Capital Management LLC Investment ManagersFinance Founded in 2009, YYC Capital Management LLC is a hedge fund manager located in New York City | Corporate Officer/Principal | 01.09.2011 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 31.10.2005 |
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 31.08.2003 |
| Advanced Tissue Sciences, Inc. | Corporate Officer/Principal | 30.11.2002 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 31.05.2002 |
Ausbildung von Sean O'Brien
| Suffolk University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
YYC Capital Management LLC
YYC Capital Management LLC Investment ManagersFinance Founded in 2009, YYC Capital Management LLC is a hedge fund manager located in New York City | Finance |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
| Advanced Tissue Sciences, Inc. | Commercial Services |
